(Q33670722)

28 July 2017

1 reference

title

Personal review: Helicobacter pylori, NSAIDs and cognitive dissonance (English)

1 reference

Helicobacter pylori infectious disease

28 July 2017

0 references

1 reference

Hawkey CJ

1

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 June 1999

1 reference

Alimentary Pharmacology & Therapeutics

28 July 2017

published in

1 reference

28 July 2017

volume

13

1 reference

28 July 2017

issue

6

1 reference

28 July 2017

page(s)

695-702

1 reference

Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00550.X

Non-steroidal anti-inflammatory drugs and peptic ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00550.X

Pathophysiology of Helicobacter pylori-induced gastritis and peptic ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00550.X

H. pylori virulence factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00550.X

Peptic ulcer bleeding in the elderly: relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00550.X

Acute perforated duodenal ulcer is not associated with Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00550.X

Prevalence of Helicobacter pylori infection and its effect on symptoms and non-steroidal anti-inflammatory drug induced gastrointestinal damage in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00550.X

Effect of non-steroidal anti-inflammatory drugs on dyspeptic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00550.X

Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00550.X

Predicting NSAID related ulcers--assessment of clinical and pathological risk factors and importance of differences in NSAID

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00550.X

Campylobacter-like organisms, nonsteroidal anti-inflammatory drugs and gastric lesions in patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00550.X

Chemical gastritis and Helicobacter pylori related gastritis in patients receiving non-steroidal anti-inflammatory drugs: comparison and correlation with peptic ulceration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00550.X

Serological evidence of infection with Helicobacter pylori may predict gastrointestinal intolerance to non-steroidal anti-inflammatory drug (NSAID) treatment in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00550.X

Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00550.X

De-Nol stimulates gastric and duodenal alkaline secretion through prostaglandin dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00550.X

Effect of curing Helicobacter pylori infection on intragastric acidity during treatment with ranitidine in patients with duodenal ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00550.X

Abolition by omeprazole of aspirin induced gastric mucosal injury in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00550.X

Basic fibroblast growth factor and PDGF in GI diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00550.X

Helicobacter pylori infection induces gastric cancer in mongolian gerbils

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00550.X

NSAID use and decreased risk of gastrointestinal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00550.X

A controlled study of ranitidine for the prevention of recurrent hemorrhage from duodenal ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00550.X

Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00550.X

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00550.X

Ecology of Helicobacter pylori in the human stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00550.X

10.1046/J.1365-2036.1999.00550.X

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference